Published date: Apr 29 2022

Journal Title: Journal of Ophthalmic and Vision Research

Issue title: April–June 2022, Volume 17, Issue 2

Pages: 306 – 308

DOI: 10.18502/jovr.v17i2.10808

Vidhi BajpaiDepartment of Ophthalmology, Lady Hardinge Medical College & Associated Hospitals, University of Delhi, New Delhi, India

Siddharth Madandrsiddharthmadan@gmail.comDepartment of Ophthalmology, University College of Medical Sciences and Associated GTB Hospital, University of Delhi, New Delhi, India

Gunjan RanaDepartment of Ophthalmology, Lady Hardinge Medical College & Associated Hospitals, University of Delhi, New Delhi, India

This is a Letter to the Editor and does not have an abstract. Please download the PDF or view the article HTML.

Keywords: NA, Not applicable, None

1. Aghdam KA, Sanjari MS, Manafi N, Khorramdel S, Alemzadeh SA, Navahi RAA. Temporal artery biopsy for diagnosing giant cell arteritis: a ten-year review. J Ophthalmic Vis Res 2020;15:201–209.

2. Hayreh SS. Management of ischemic optic neuropathies. Indian J Ophthalmol 2011;59:123–136.

3. Pierro L, Arrigo A, Aragona E, Cavalleri M, Bandello F. Vessel density and vessel tortuosity quantitative analysis of arteritic and non-arteritic anterior ischemic optic neuropathies: an optical coherence tomography angiography study. J Clin Med 2020;9:E1094.

4. Inanc M, Tekin K, Budakoglu O, Ilhan B, Aydemir O, Yilmazbas P. Could platelet indices and neutrophil to lymphocyte ratio be new biomarkers for differentiation of arteritic anterior ischemic neuropathy from non-arteritic type? Neuroophthalmology 2018;42:287–294.

5. Sugihara T, Hasegawa H, Uchida HA, Yoshifuji H, Watanabe Y, Amiya E, et al. Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions. Arthritis Res Ther 2020;22:72.

6. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 2012;11:A544–A554.